Abstract:Hongfeng Wu, 1 Zhongtao Li, 2 Jiaoqing Tang, 2 Xiao Yang, 1 Yong Zhou, 3 Bo Guo, 4 Lin Wang, 2 Xiangdong Zhu, 1 Chongqi Tu, 3 Xingdong Zhang 1 1 National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China; 2 Department of Dermatology, West China Hospital of Sichuan University, Chengdu 610041, China; 3 Department of Orthopaedics, West China Hospital of Sichuan University, Chengdu 610041, China; 4 Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu 610041, China Background: Treatment for melanoma is a challenging clinical problem, and some new strategies are worth exploring. Purpose: The objective of this study was to investigate the in vitro and in vivo anti-melanoma effects of hydroxyapatite nanoparticles (HANPs) and discuss the involved material factors. Materials and methods: Five types of HANPs, ie, HA-A, HA-B, HA-C, HA-D, and HA-E, were prepared by wet chemical method combining with polymer template and appropriate post-treatments. The in vitro effects of the as-prepared five HANPs on inhibiting the viability of A375 melanoma cells and inducing the apoptosis of the cells were evaluated by Cell Counting Kit-8 analysis, cell nucleus morphology observation, flow cytometer, and PCR analysis. The in vivo anti-melanoma effects of HANPs were studied in the tumor model of nude mice. Results: The five HANPs had different physicochemical properties, including morphology, size, specific surface area (SSA), crystallinity, and so on. By the in vitro cell study, it was found that the material factors played important roles in the anti-melanoma effect of HANPs. Among the as-prepared five HANPs, HA-A with granular shape, smaller size, higher SSA, and lower crystallinity exhibited best effect on inhibiting the viability of A375 cells. At the concentration of 200 μg/mL, HA-A resulted in the lowest cell viability (34.90%) at day 3. All the HANPs could induce the apoptosis of A375 cells, and the relatively higher apoptosis rates of the cells were found in HA-A (20.10%) and HA-B (19.41%) at day 3. However, all the HANPs showed no inhibitory effect on the viability of the normal human epidermal fibroblasts. The preliminary in vivo evaluation showed that both HA-A and HA-C could delay the formation and growth speed of melanoma tissue significantly. Likely, HA-A exhibited better effect on inhibiting the growth of melanoma tissue than HA-C. The inhibition rate of HA-A for tumor tissue growth reached 49.1% at day 23. Conclusion: The current study confirmed the anti-melanoma effect of HANPs and provided a new idea for the clinical treatment of melanoma. Keywords: hydroxyapatite, nanoparticles, melanoma cells, fibroblasts, viability, apoptosis, tumor, suppression

A Selective Reduction of Osteosarcoma by Mitochondrial Apoptosis Using Hydroxyapatite Nanoparticles

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles

Anti-melanoma Effect and Action Mechanism of a Novel Chitosan-Based Composite Hydrogel Containing Hydroxyapatite Nanoparticles

Biological Response of Osteosarcoma Cells to Size-Controlled Nanostructured Hydroxyapatite

Antitumor Effect by Hydroxyapatite Nanospheres: Activation of Mitochondria-Dependent Apoptosis and Negative Regulation of Phosphatidylinositol-3-Kinase/Protein Kinase B Pathway.

Selective Effects of Hydroxyapatite Nanoparticles on Osteosarcoma Cells and Osteoblasts.

The Morphology of Hydroxyapatite Nanoparticles Regulates Clathrin-Mediated Endocytosis in Melanoma Cells and Resultant Anti-Tumor Efficiency

Hierarchically Structured Hydroxyapatite Particles Facilitate the Enhanced Integration and Selective Anti-Tumor Effects of Amphiphilic Prodrug for Osteosarcoma Therapy.

Hierarchically Constructed Selenium-Doped Bone-Mimetic Nanoparticles Promote ROS-mediated Autophagy and Apoptosis for Bone Tumor Inhibition.

Mitochondria-Targeted Hydroxyapatite Nanoparticles for Selective Growth Inhibition of Lung Cancer in Vitro and in Vivo

Selective Effect of Hydroxyapatite Nanoparticles on Osteoporotic and Healthy Bone Formation Correlates with Intracellular Calcium Homeostasis Regulation

Zoledronic Acid-Loaded Hybrid Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticle: Novel Fabrication and Safety Verification

HIF-1-Mediated Mitophagy Determines ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death both In Vitro and In Vivo

Ph-Responsive Hydrogel with Gambogic Acid and Calcium Nanowires for Promoting Mitochondrial Apoptosis in Osteosarcoma

Catechins-Modified Selenium-Doped Hydroxyapatite Nanomaterials for Improved Osteosarcoma Therapy Through Generation of Reactive Oxygen Species.

The in vitro and in vivo anti-melanoma effects of hydroxyapatite nanoparticles: influences of material factors

Selenium-substituted Hydroxyapatite Nanoparticles and Their in Vivo Antitumor Effect on Hepatocellular Carcinoma

Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms

Biomimetic Engineered Nanoparticles Target Drug-Resistant Tumor Cells and Heterogeneous Blood Vessels for Combination Therapy of Osteosarcoma

Polydopamine-coated UiO-66 Nanoparticles Loaded with Perfluorotributylamine/tirapazamine for Hypoxia-Activated Osteosarcoma Therapy